Cardiac Disease Modeling
The pathophysiological cellular phenotypes of genetically heritable heart diseases can be modeled using disease-specific human induced pluripotent stem cell cardiomyocyte (hiPSC-CM). Modeling enables broader understanding of the mechanisms leading to compromised electrical and contractile coupling.
Real-Time Cell Analysis for Cardiovascular Research
Real-time, functional cell analysis of cardiomyocytes provides novel and sensitive measurements for cardiac disease research to reveal critical pathways and identify drug targets.
With Agilent cell analysis technologies, expand your drug development pipeline by examining drug compounds affecting contractile processes, cardiotoxicity, cardiovascular disease, and cardiac safety. Perform disease-specific modeling with human induced pluripotent stem cell cardiomyocytes (hiPSC-CM) to understand the underlying causes of these cardiomyopathies.